CrushSCI.com
181.1Average days
113.5Median days
19Fastest days
973Longest days
282025 publications

Paper Review Records

All Paper Review Records

16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

973 days

Decisional conflict among patients with prostate cancer considering germline testing

Authors
Liam Gima-Lange; Kelly Gordon; Barry Tong; Amie Blanco; Daniel H. KwonShow moreShow less
Affiliations
1. Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, USA; 2. Cancer Genetics and Prevention Program, University of California San Francisco, San Francisco, USA; 3. Department of Medicine, University of California San Francisco, San Francisco, USAShow moreShow less
Source PDF DOI Publisher page
220 days

BRCA2 reversion mutations as a resistance mechanism to olaparib in patients with BRCA2 -mutated mCRPC: a case series

Authors
Kohji Takemura; Ayumi Abe; Kazushige Sakaguchi; Shinji Urakami; Masami Arai; Yuji MiuraShow moreShow less
Affiliations
1. Department of Medical Oncology, Toranomon Hospital, Tokyo, Japan; 2. Department of Advanced Medical Development, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan; 3. Clinical Genetics Center, Toranomon Hospital, Tokyo, Japan; 4. Department of Clinical Genetics, Graduate School of Medicine, Juntendo University, Tokyo, Japan; 5. Department of Urology, Toranomon Hospital, Tokyo, Japan; 6. Department of Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, JapanShow moreShow less
Source PDF DOI Publisher page
77 days

Awareness of hereditary breast cancer and readiness for genetic testing among newly diagnosed patients with breast cancer in Nigeria: a multicentre study

Authors
Funmilola O. Wuraola; Jenine Ramruthan; Victoria L. Mango; Nneka Sunday-Nweke; Olayide Agodirin; Anna Dare; Adewale A. Aderounmu; Mary Ogunyemi; Boladuro Olawale; Saheed Lawal; Anna T. Santiago; Olalekan Olasehinde; Adewale O. Adisa; Emma Reel; Olusegun I. Alatise; Tulin D. CilShow moreShow less
Affiliations
1. Department of Surgery, Faculty of Clinical Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria; 2. African Research Group for Oncology, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria; 3. Department of General Surgery, Princess Margaret Cancer Centre - University Health Network, Toronto, Canada; 4. Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, USA; 5. Department of Surgery, Alex Ekwueme Federal University Teaching Hospital, Abakaliki, Nigeria; 6. Department of Surgery, University of Ilorin, Ilorin, Nigeria; 7. Department of Surgery, University of Toronto, Toronto, Canada; 8. Department of Surgery, Dalla Lana School of Public Health, Toronto, Canada; 9. Department of Biostatistics, University Health Network, Toronto, CanadaShow moreShow less
Source PDF DOI Publisher page
51 days

Trends in the uptake of nipple sparing mastectomy in BRCA1/2 , PALB2 and other pathogenic variant carriers undergoing risk reducing mastectomy

Authors
Marya Alsuhaibani; Amel Melanson; Alex Viezel-Mathieu; Tassos Dionisopoulos; Mark Basik; Jean Francois Boileau; Karyne Martel; Sarkis Meterissian; Joshua Vorstenbosch; Victor Villareal-Corpuz; William D. Foulkes; Ipshita Prakash; Stephanie M. WongShow moreShow less
Affiliations
1. Department of Surgery, McGill University, Montreal, Canada; 2. Stroll Cancer Prevention Centre, Jewish General Hospital, Montreal, Canada; 3. Department of Plastic and Reconstructive Surgery, McGill University, Montreal, Canada; 4. Department of Oncology, McGill University, Montreal, Canada; 5. Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada; 6. Department of Human Genetics, McGill University, Montreal, Canada; 7. Segal Cancer Centre, Jewish General Hospital, Montreal, CanadaShow moreShow less
Source PDF DOI Publisher page
119 days

Barriers and facilitators of adherence to cancer prevention in Lynch Syndrome: an integrative review

Authors
Marjorie Matekwa; Margaret H. White; Janet H. Van Cleave; Veronica J. Brady; Carina KatigbakShow moreShow less
Affiliations
1. Cizik School of Nursing, The University of Texas Health Science Center at Houston (UTHealth Houston), Houston, USAShow moreShow less
Source PDF DOI Publisher page
103 days

The psychosocial impact of receiving a polygenic risk score informing risk of prostate cancer

Authors
Matthew Hogben; Emma Hainsworth; Barbara Benton; Jana McHugh; Kathryn Myhill; Eva McGrowder; Reshma Rageevakumar; Denzil James; Sarah Benafif; Elizabeth C. Page; Rosalind A. Eeles; Emma Rowland; Elizabeth K. BancroftShow moreShow less
Affiliations
1. Oncogenetics Research Team, The Royal Marsden NHS Foundation Trust, London, UK; 2. Oncogenetics Research Team, The Institute of Cancer Research, London, UK; 3. University College London Hospitals NHS Foundation Trust, London, UK; 4. Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care, King’s College London, London, UKShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Hereditary Cancer in Clinical Practice take to review a manuscript?

As of 2026-11-19, CrushSCI has 16 complete review records for Hereditary Cancer in Clinical Practice. The fastest paper went from submission to acceptance in 19 days (Association analysis of germline variants in GEN1 with a susceptibility to prostate cancer in Polish men, received 2026-05-13, accepted 2026-06-01); the slowest took 973 days. The average is 181.1 days and the median is 113.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.